phenytoin has been researched along with Acute Ischemic Stroke in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this propensity score-weighted population-based retrospective cohort study, we used competing risk regression analyses to determine the risks of ischemic stroke, venous thromboembolism, and death in DOAC recipients taking CYP/P-gp-modulating antiseizure medications (phenytoin, valproate, levetiracetam, carbamazepine, or phenobarbital) versus those taking CYP/P-gp-neutral antiseizure medications (pregabalin, gabapentin, or clobazam)." | 4.12 | Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis. ( Chan, HH; Chan, HY; Ip, BY; Ko, H; Lau, AY; Lau, LH; Leng, X; Leung, H; Leung, TW; Mok, VC; Soo, YO; Wong, GL; Yip, TC, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ip, BY | 3 |
| Ko, H | 3 |
| Wong, GL | 3 |
| Yip, TC | 3 |
| Lau, LH | 3 |
| Lau, AY | 3 |
| Leng, X | 3 |
| Leung, H | 3 |
| Chan, HH | 3 |
| Chan, HY | 3 |
| Mok, VC | 3 |
| Soo, YO | 3 |
| Leung, TW | 3 |
1 other study available for phenytoin and Acute Ischemic Stroke
| Article | Year |
|---|---|
Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis.
Topics: Anticoagulants; Humans; Ischemic Stroke; Levetiracetam; Phenytoin; Retrospective Studies; Valproic A | 2022 |
Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis.
Topics: Anticoagulants; Humans; Ischemic Stroke; Levetiracetam; Phenytoin; Retrospective Studies; Valproic A | 2022 |
Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis.
Topics: Anticoagulants; Humans; Ischemic Stroke; Levetiracetam; Phenytoin; Retrospective Studies; Valproic A | 2022 |
Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis.
Topics: Anticoagulants; Humans; Ischemic Stroke; Levetiracetam; Phenytoin; Retrospective Studies; Valproic A | 2022 |
Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis.
Topics: Anticoagulants; Humans; Ischemic Stroke; Levetiracetam; Phenytoin; Retrospective Studies; Valproic A | 2022 |
Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis.
Topics: Anticoagulants; Humans; Ischemic Stroke; Levetiracetam; Phenytoin; Retrospective Studies; Valproic A | 2022 |
Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis.
Topics: Anticoagulants; Humans; Ischemic Stroke; Levetiracetam; Phenytoin; Retrospective Studies; Valproic A | 2022 |
Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis.
Topics: Anticoagulants; Humans; Ischemic Stroke; Levetiracetam; Phenytoin; Retrospective Studies; Valproic A | 2022 |
Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis.
Topics: Anticoagulants; Humans; Ischemic Stroke; Levetiracetam; Phenytoin; Retrospective Studies; Valproic A | 2022 |